Search results
Exploring Novartis And Two More High-Yield Dividend Stocks In Switzerland
Simply Wall St. via Yahoo Finance· 11 hours agoThe Switzerland market recently experienced a moderate decline, influenced by investor concerns that...
Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Novartis AG...
Investing in the heart of Central Europe - Foreign Policy
Foreign Policy Magazine· 5 hours agoSituated in the heart of Europe, Hungary represents a beacon of economic resilience and investment...
FreightTech Friday: Learn to Win raises $30M, captures the industry’s attention
FreightWaves via Yahoo Finance· 3 hours agoThis week, training software for the DOD is serving the freight community; CargoSense closes its...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 2 days agoThe move follows similar billion-dollar-plus transactions made in recent months by Bristol Myers Squibb (BMS) and Eli Lilly, along with earlier takeovers...
What's in a Name: Defining Difficult-to-Treat axSpA and PsA
Medscape· 10 hours agoDespite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...
Study Elucidates Skin Signs of VEXAS Syndrome
Medscape· 10 hours agoSkin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 10 hours agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
Real-World RA Data Find JAK Inhibitor Infection Risk Is Low
Medscape· 10 hours agoIn patients with rheumatoid arthritis (RA), Janus kinase inhibitors (JAKi) are associated with a...
Erasca (NASDAQ:ERAS) vs. Ascendis Pharma A/S (NASDAQ:ASND) Head-To-Head Contrast
ETF DAILY NEWS· 13 hours agoErasca (NASDAQ:ERAS – Get Free Report) and Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses ...